Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response
NCT03254121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93
Last updated 2021-02-18
Summary
In this international collaboration study, the research group will analyze somatic mutations of hepatocellular carcinoma (HCC) developed after sustained virological response (SVR) in patients treated with hepatitis C (HCV) therapy
Conditions
- Hepatocellular Carcinoma
- Hepatitis C
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Jan Bolinder, Prof · Karolinska Institutet
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2020-09-01
- Completion
- 2020-09-01
Countries
- Sweden
Study Locations
More Related Trials
-
A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)
NCT02859324 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment
NCT03389126 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
NCT05359861 ·Status: COMPLETED ·Phase: PHASE2
-
First Line Hepato Cellular Carcinoma (HCC)
NCT00858871 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Antiviral Therapy on Patients With HBV-related HCC
NCT05406089 ·Status: COMPLETED
-
Prospective Liver Study
NCT01539993 ·Status: COMPLETED
-
Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment
NCT05113290 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer
NCT05371873 ·Status: UNKNOWN
-
Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate
NCT00006332 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
NCT06789757 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment
NCT01232296 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
NCT00913757 ·Status: COMPLETED
-
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)
NCT06590246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
NCT05184400 ·Status: RECRUITING
-
Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
NCT04646928 ·Status: UNKNOWN
-
Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC
NCT02563158 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma
NCT06695026 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
NCT05417932 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
NCT02191878 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
NCT02954094 ·Status: ACTIVE_NOT_RECRUITING
-
Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
NCT00287222 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)
NCT00517920 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
NCT06530251 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)
NCT01521780 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
NCT07039201 ·Status: RECRUITING ·Phase: NA